Deutsche Bank
NBRV

Deutsche Bank’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Deutsche Bank’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-106
Closed -$14K – 4617
2020
Q3 		$14K Buy
+106
New +$17.7K ﹤0.01% 4163
2020
Q1 		– Sell
-201
Closed -$66K – 5102
2019
Q4 		$66K Buy
+201
New +$92.2K ﹤0.01% 3818
2019
Q3 		– Hold
0
– – – 5458
2019
Q2 		– Sell
-348
Closed -$213K – 5627
2019
Q1 		$212K Buy
348
+342
+5,700% +$187K ﹤0.01% 3969
2018
Q4 		$2K Sell
6
-32
-84% -$17.2K ﹤0.01% 5078
2018
Q3 		$26K Sell
38
-15
-28% -$10.6K ﹤0.01% 4884
2018
Q2 		$46K Buy
53
+24
+83% +$27.5K ﹤0.01% 4808
2018
Q1 		$35K Sell
29
-305
-91% -$451K ﹤0.01% 4868
2017
Q4 		$499K Buy
334
+2
+0.6% +$3.16K ﹤0.01% 3602
2017
Q3 		$679K Buy
332
+172
+108% +$403K ﹤0.01% 3250
2017
Q2 		$417K Sell
160
-209
-57% -$539K ﹤0.01% 3549
2017
Q1 		$1.11M Sell
369
-139
-27% -$338K ﹤0.01% 2588
2016
Q4 		$755K Buy
508
+188
+59% +$250K ﹤0.01% 2885
2016
Q3 		$564K Buy
320
+40
+14% +$77.2K ﹤0.01% 3135
2016
Q2 		$524K Buy
+280
New +$564K ﹤0.01% 3260

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Deutsche Bank's NBRV Position: Q4 2020 in Review

Deutsche Bank sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2020, closing a stake of 106 shares — an estimated $14K sold.

Deutsche Bank first reported a position in NBRV in Q2 2016 and held it in 14 quarters. The position peaked at $1.11M in Q1 2017. 33 funds tracked by Wall St. Rank hold NBRV as of Q4 2020.

  • Deutsche Bank reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2020 after selling out during the quarter.
  • Deutsche Bank sold 106 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2020, an estimated $14K.
  • Deutsche Bank first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2016 and held it in 14 quarters.
  • Deutsche Bank's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $1.11M in Q1 2017.
  • 33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2020.

Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.